Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Epidemiology and treatment of multiple sclerosis in elderly populations
CB Vaughn, D Jakimovski, KS Kavak… - Nature Reviews …, 2019 - nature.com
The prevalence of multiple sclerosis (MS) and the age of affected patients are increasing
owing to increased longevity of the general population and the availability of effective …
owing to increased longevity of the general population and the availability of effective …
Interplay between age and neuroinflammation in multiple sclerosis: effects on motor and cognitive functions
A Musella, A Gentile, FR Rizzo, F De Vito… - Frontiers in aging …, 2018 - frontiersin.org
Aging is one of the main risk factors for the development of many neurodegenerative
diseases. Emerging evidence has acknowledged neuroinflammation as potential trigger of …
diseases. Emerging evidence has acknowledged neuroinflammation as potential trigger of …
CSF cytokines in aging, multiple sclerosis, and dementia
Inflammation is a common process involved in aging, multiple sclerosis (MS), and age-
related neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's …
related neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's …
Effects of exercise in people with multiple sclerosis: a systematic review and meta-analysis
L Du, H **, S Zhang, Y Zhou, X Tao, Y Lv… - Frontiers in public …, 2024 - frontiersin.org
Background A growing body of studies have examined the effect of exercise in people with
multiple sclerosis (MS), while findings of available studies were conflicting. This meta …
multiple sclerosis (MS), while findings of available studies were conflicting. This meta …
Aging with multiple sclerosis: prevalence and profile of cognitive impairment
M Branco, L Ruano, E Portaccio, B Goretti… - Neurological …, 2019 - Springer
Background The increase in life expectancy of patients with multiple sclerosis (MS) requires
a better knowledge of disease features in the older patients group. Objective To describe the …
a better knowledge of disease features in the older patients group. Objective To describe the …
[HTML][HTML] Lower extremity muscle power–A critical determinant of physical function in aging and multiple sclerosis
RAW Stagsted, C Ramari, AG Skjerbaek, C Thrue… - Experimental …, 2021 - Elsevier
Background and purpose In aging, lower extremity muscle power is undoubtedly one of the
most important parameters of neuromuscular function implicating lower extremity physical …
most important parameters of neuromuscular function implicating lower extremity physical …
Physical activity and walking performance across the lifespan among adults with multiple sclerosis
Background There is consistent evidence of an association between physical activity and
walking performance in persons with multiple sclerosis (MS). To date, this relationship has …
walking performance in persons with multiple sclerosis (MS). To date, this relationship has …
Lower extremity muscle strength across the adult lifespan in multiple sclerosis: implications for walking and stair climbing capacity
PS Sieljacks, CA Søberg, AS Michelsen… - Experimental …, 2020 - Elsevier
Introduction Persons with multiple sclerosis (pwMS) accumulate impairments in muscle
strength and limitations in physical function as the disease progresses. The same symptoms …
strength and limitations in physical function as the disease progresses. The same symptoms …
Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective
Accumulating evidence suggests that the detrimental effect of nicotine and tobacco smoke
on the central nervous system (CNS) is caused by the neurotoxic role of nicotine on blood …
on the central nervous system (CNS) is caused by the neurotoxic role of nicotine on blood …
[HTML][HTML] Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the …
Introduction Approximately one-third of all persons with multiple sclerosis (pwMS) are older,
ie, having an age≥ 60 years. Whilst ageing and MS separately elicit deteriorating effects on …
ie, having an age≥ 60 years. Whilst ageing and MS separately elicit deteriorating effects on …